Prenatal effects of maternal-fetal HLA compatibility. 1987

C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois 60611.

Both retrospective studies of idiopathic aborters, as well as prospective studies of normal couples, have shown reduced fertility among couples sharing HLA antigens. However, the effects of maternal-fetal histocompatibility on surviving embryos are largely univestigated. We thus prospectively studied 53 healthy, fertile women whose timed pregnancies were verified within 21 days of conception. Maternal-fetal histocompatibility status was determined for HLA-A,-B, and -DR locus antigens. Fetal growth rates were monitored by ultrasound at 8, 12, and 20 weeks gestation. Neonates were weighed, measured (birthlength, chest circumference, head circumference), and examined within 72 h of delivery (116 major and minor anomalies) in standardized fashion by one of two geneticists. Although no significant differences were found between infants compatible and incompatible at the HLA-A or HLA-B locus, significant differences were observed between HLA-DR compatible and incompatible infants for sex ratios (p less than .003) and minor anomaly rates (p less than .05). Although differences in mean birthweights between HLA-DR compatible and incompatible infants were not significant in this sample, HLA-DR compatible infants were on average 200 grams smaller than HLA-DR incompatible infants. We interpret these findings as evidence for selection against histocompatible fetuses throughout gestation, particularly with respect to HLA-DR compatibility. Potential immunologic and genetic mechanisms are discussed.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005314 Embryonic and Fetal Development Morphological and physiological development of EMBRYOS or FETUSES. Embryo and Fetal Development,Prenatal Programming,Programming, Prenatal
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
January 1997, Immunogenetics,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
July 1988, Akusherstvo i ginekologiia,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
January 2021, Frontiers in immunology,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
January 2023, Frontiers in immunology,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
June 2010, Arthritis and rheumatism,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
November 1987, Tissue antigens,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
July 2005, Tissue antigens,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
April 2024, Journal of clinical medicine,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
December 2016, Placenta,
C Ober, and J L Simpson, and M Ward, and R M Radvany, and R Andersen, and S Elias, and R Sabbagha
March 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Copied contents to your clipboard!